Larimar Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 3.85 -0.02 (0.52%)
Previous Close $3.87    52 Week High
Open $3.82    52 Week Low
Day High $3.86    P/E N/A 
Day Low $3.74    EPS
Volume 870,888